(A) Time taken to reach platform in hidden trail, (B) Time taken to reach platform in visible trail, (C) Latency time to reach platform zone and (D) Time spent in platform zone in... by Hammad Ismail (4227988)

(A) Mobility distance (B) Explored areas, (C) Immobility time for open field test. by Hammad Ismail (4227988)

(A) Time spent in closed arm, (B) Time spent in open arm, (C) Number of entries in closed arm, (D) Number of entries in open arm, and (E) Latency time to enter open arm for elevate... by Hammad Ismail (4227988)

(A) Time spent in light compartment, (B) Number of transitions between compartments, (C) Number of head pokes to light compartment for light-dark compartment test. by Hammad Ismail (4227988)

(A) Number of crossings, (B) Number of rearings, (C) Latency time for novel object, (D) Familiar object exploration time, (E) Novel object exploration time for novel object recogni... by Hammad Ismail (4227988)

(A) Mobility rate, (B) Explored areas, (5C) Immobility time, (D) Frozen events for hole board test. by Hammad Ismail (4227988)

(A) Immobility time, (B) Frozen events for forced swim test. by Hammad Ismail (4227988)

(A) Serotonin and (B) Dopamine levels in brain tissues. by Hammad Ismail (4227988)

(A) Duration of contacts, (B) Distance covered, (C) Number of interacting contacts, (D) Number of frozen events for social interaction test. by Hammad Ismail (4227988)

Baseline characteristics of participants. by Hyungjong Park (10147327)

“…In the multivariable Cox regression analysis, eGFR > 120 mL/min ∙ 1.73 m² was associated with a decreased risk of dyslipidemia (HR: 0.35; 95% CI [0.34–0.36]). …”

Baseline Characteristics of Study Participants. by Swati M. Surkar (8399427)

“…The results demonstrate that DT training significantly improves and retains DT performance, likely due to a reduction in cognitive-motor interference. …”

Raw and processed data files. by Swati M. Surkar (8399427)

“…The results demonstrate that DT training significantly improves and retains DT performance, likely due to a reduction in cognitive-motor interference. …”

HBV RNaseH inhibitors effects on capsid accumulation occur independent of HBV DNA synthesis. by Daniel P. Bradley (10306893)

Effects of 1466 on capsid and pgRNA encapsidation compared to known CAM-A and CAM-E inhibitors. by Daniel P. Bradley (10306893)

Screening HBV RNaseH inhibitors in HepDES19 cell for effects on capsids and core protein. by Daniel P. Bradley (10306893)

1466 inhibits capsid accumulation independent of HBV replication. by Daniel P. Bradley (10306893)

Differences among the classes of CAMs. by Daniel P. Bradley (10306893)

“…Some <i>N</i>-hydroxypyridinedione (HPD) HBV RNaseH inhibitors significantly reduced accumulation of capsids in HBV-replicating cells. …”

Changes in the genotypes of <i>NLRP1</i>, <i>NLRP3</i>, and <i>NLRP4</i>. by Hao Deng (409186)

Subjects:

Change in the genotypes of <i>ATM</i>, <i>ERCC1</i>, and <i>XRCC1</i>. by Hao Deng (409186)

Subjects:

Effect of the interaction of drinking, smoking and <i>ERCC1</i> rs3212986 on workers exposed to coal dust. by Hao Deng (409186)

Subjects: